Growth Metrics

Scholar Rock Holding (SRRK) Other Gross PP&E Adjustments (2017 - 2026)

Scholar Rock Holding's quarterly Other Gross PP&E Adjustments came in at -$18.3 million in Q1 2026, up 8.73% year-on-year from -$16.8 million in Q1 2025, and down 872.36% quarter-over-quarter from $2.4 million in Q4 2025.

Scholar Rock Holding has reported Other Gross PP&E Adjustments for 10 years, with the latest figure at -$18.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 8.73% year-over-year to -$18.3 million; the trailing twelve-month figure through Mar 2026 stood at -$18.3 million (up 8.73% YoY), and the FY2025 full-year result was $2.4 million, up 180.04% from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 stood at -$18.3 million, down from $2.4 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was $2.4 million in Q4 2025, with the low at -$25.2 million in Q1 2022.
  • Average Other Gross PP&E Adjustments over 5 years is -$15.7 million, with a median of -$18.7 million recorded in 2023.
  • Year-over-year, Other Gross PP&E Adjustments slumped 232.07% in 2024 and jumped 180.04% in 2025.
  • Tracing SRRK's Other Gross PP&E Adjustments over 5 years: stood at -$8.4 million in 2022, then surged by 126.64% to $2.2 million in 2023, then tumbled by 232.07% to -$3.0 million in 2024, then jumped by 180.04% to $2.4 million in 2025, then tumbled by 872.36% to -$18.3 million in 2026.
  • The last three Other Gross PP&E Adjustments figures came in at -$18.3 million (Q1 2026), $2.4 million (Q4 2025), and -$21.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - -18.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -18.31 Mn
Mar 31, 2026 -18.31 Mn
Dec 31, 2025 2.37 Mn
Dec 31, 2025 2.37 Mn
Sep 30, 2025 -21.13 Mn
Sep 30, 2025 -21.13 Mn
Jun 30, 2025 -23.31 Mn
Jun 30, 2025 -23.31 Mn
Mar 31, 2025 -20.06 Mn
Mar 31, 2025 -20.06 Mn
Dec 31, 2024 -2.96 Mn
Dec 31, 2024 -2.96 Mn
Sep 30, 2024 -20.25 Mn
Sep 30, 2024 -20.25 Mn
Jun 30, 2024 -22.23 Mn
Jun 30, 2024 -22.23 Mn
Mar 31, 2024 -13.72 Mn
Mar 31, 2024 -13.72 Mn
Dec 31, 2023 2.24 Mn
Dec 31, 2023 2.24 Mn
Sep 30, 2023 -15.03 Mn
Sep 30, 2023 -15.03 Mn
Jun 30, 2023 -16.37 Mn
Jun 30, 2023 -16.37 Mn
Mar 31, 2023 -18.66 Mn
Mar 31, 2023 -18.66 Mn
Dec 31, 2022 -8.42 Mn
Dec 31, 2022 -8.42 Mn
Sep 30, 2022 -21.70 Mn
Sep 30, 2022 -21.70 Mn
Jun 30, 2022 -24.05 Mn
Jun 30, 2022 -24.05 Mn
Mar 31, 2022 -25.21 Mn
Mar 31, 2022 -25.21 Mn
Dec 31, 2021 -13.34 Mn
Dec 31, 2021 -13.34 Mn
Sep 30, 2021 -28.61 Mn
Sep 30, 2021 -28.61 Mn
Jun 30, 2021 -29.89 Mn
Jun 30, 2021 -29.89 Mn
Mar 31, 2021 -31.53 Mn
Mar 31, 2021 -31.53 Mn
Dec 31, 2020 -21.17 Mn
Dec 31, 2020 -21.17 Mn
Sep 30, 2020 -35.95 Mn
Sep 30, 2020 -35.95 Mn
Jun 30, 2020 -5.16 Mn
Jun 30, 2020 -5.16 Mn
Mar 31, 2020 -5.11 Mn
Mar 31, 2020 -5.11 Mn
Dec 31, 2019 2.23 Mn
Dec 31, 2019 2.23 Mn
Sep 30, 2019 -6.01 Mn
Sep 30, 2019 -6.01 Mn
Jun 30, 2019 -5.73 Mn
Jun 30, 2019 -5.73 Mn
Mar 31, 2019 -5.73 Mn
Mar 31, 2019 -5.73 Mn
Dec 31, 2018 4.61 Mn
Dec 31, 2018 4.61 Mn
Sep 30, 2018 4.36 Mn
Sep 30, 2018 4.36 Mn
Jun 30, 2018 3.13 Mn
Jun 30, 2018 3.13 Mn
Dec 31, 2017 3.35 Mn
Dec 31, 2017 3.35 Mn